Virginia 2023 Regular Session

Virginia Senate Bill SB1424

Introduced
1/11/23  
Refer
1/11/23  
Report Pass
2/3/23  
Engrossed
2/6/23  
Refer
2/13/23  
Report Pass
2/16/23  
Enrolled
2/24/23  
Chaptered
3/21/23  

Caption

Naloxone or other opioid antagonists; persons authorized to administer.

Impact

The legislation is poised to have a significant impact on state public health policies regarding substance abuse prevention. By permitting a wider range of individuals to administer naloxone, the bill encourages a proactive approach to emergency responses in situations involving potential overdoses. As public places increasingly adopt naloxone programs, the likelihood of successful overdose reversals rises, potentially saving lives and reducing the burden on emergency medical services. Furthermore, it fosters a community-oriented approach to health and safety, empowering everyday citizens to play a role in crisis situations concerning opioid use.

Summary

SB1424, also known as the Naloxone Access Bill, aims to expand the authorized administration and dispensing of naloxone and other opioid antagonists in efforts to combat the alarming rise in opioid overdoses. The bill allows various trained individuals, including law enforcement officers, school personnel, and emergency medical services providers, to administer naloxone in emergencies. Importantly, it establishes protocols under which naloxone can be dispensed without the need for a prior prescription, enhancing its accessibility for individuals at risk of experiencing or witnessing an opioid overdose.

Sentiment

The general sentiment surrounding SB1424 is largely positive, particularly among public health advocates and community organizations striving to mitigate the public health crisis posed by opioid misuse. Supporters hail the expanded access to life-saving medication as a necessary and timely measure. However, some skepticism exists surrounding the implications of allowing non-medical personnel to administer medications, with concerns about proper training and accountability. Overall, the supportive narrative emphasizes the urgent need for comprehensive strategies to address the opioid epidemic.

Contention

Notable points of contention in the discussions about SB1424 include debates over the adequacy of training for individuals authorized to administer naloxone and concerns regarding access to naloxone in various community settings. Critics argue that bypassing traditional prescription routes may lead to misuse or improper administration. Proponents counter that the benefit of widespread accessibility greatly outweighs potential risks, asserting that timely naloxone administration can be crucial during overdose emergencies.

Companion Bills

VA HB1709

Same As Naloxone or other opioid antagonists; persons authorized to administer.

Similar Bills

VA HB1637

Opioid antagonists; dispensing and administration by person acting on behalf of an organization.

VA SB790

Opioid antagonists; dispensing and administration by person acting on behalf of an organization.

VA SB1035

Opioid antagonists; dispensing and administration by person acting on behalf of an organization.

VA SB1257

Student & campus safety; opioid antagonist administration training for resident assistants required.

VA HB342

Naloxone or other opioid antagonists; possession by state agencies, guidelines for private employer.

VA SB1415

Opioids; impact reduction registry, report.

VA HB1447

Controlled substances; administration by emergency medical providers.

VA SB1426

Controlled substances; administration by emergency medical providers.